申请人:Ewha University-Industry Collaboration Foundation
公开号:EP2947081A1
公开(公告)日:2015-11-25
This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors.
本发明涉及作为转化生长因子-β(TGF-β)Ⅰ型受体(ALK5)和/或激活素Ⅰ型受体(ALK4)抑制剂的 2-吡啶基取代的咪唑(I)、其制备方法及其在医学中的用途,特别是在治疗和预防由这些受体介导的疾病状态中的用途。